Buy Cancer Apr 2026

: Rated as a Strong Buy by Piper Sandler for its work in overcoming treatment resistance.

: Analysts maintain an Overweight rating , forecasting significant upside potential. If you're looking for more info, are you interested in: Specific types of cancer treatments (like CAR-T or ADCs)? Financial analysis of these stocks? Clinical trial details for these new acquisitions? buy cancer

: Large firms like Eli Lilly and Novartis are racing to replace revenue from older drugs that are nearing patent expiration. : Rated as a Strong Buy by Piper

Novartis to Buy Breast-Cancer Drug From Synnovation ... - WSJ buy cancer

Novartis agreed to acquire an experimental breast-cancer drug from Synnovation Therapeutics for up to $3 billion.